SP2456

SP2456 is an experimental small molecule compound classified as an N-acyl-alpha amino acid derivative. Its chemical formula is C25H33Cl2N7O2 and it has a molecular weight of approximately 534.5 g/mol. The primary mechanism of action for SP2456 is inhibition of interleukin‑2 (IL‑2), suggesting potential immunomodulatory or anti-inflammatory effects. It has not been approved for any indication and remains at the discovery or preclinical stage with no reported clinical trials beyond phase 0[1][3][4].

Other names

(2R)-2-cyclohexyl-2-(diaminomethylideneamino)-N-[2-[4-[3-(2,3-dichlorophenyl)-1H-pyrazol-5-yl]piperidin-1-yl]-2-oxoethyl]acetamide2-CYCLOHEXYL-N-(2-{4-[5-(2,3-DICHLORO-PHENYL)-2H-PYRAZOL-3-YL]-PIPERIDIN-1-YL}-2-OXO-ETHYL)-2-GUANIDINO-ACETAMIDE(R)-2-Cyclohexyl-N-(2-{4-[5-(2,3-dichloro-phenyl)-2H-pyrazol-3-yl]-piperidin-1-yl}-2-oxoethyl)-2-guani­­dino-acetamide